Skip to search formSkip to main contentSkip to account menu

ceronapril

Known as: 1-(6-amino-2-((hydroxy(4-phenylbutyl)phosphinyl)oxy)-1-oxohexyl)proline, ceranapril 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Lipophilicities of seven structurally diverse angiotensin-converting enzyme (ACE) inhibitors, viz., captopril, zofenoprilat… 
1999
1999
The background for these investigations was the discovery that formation of angiotensin II by the renin angiotensin system can… 
1997
1997
1 The ability of 5‐HT2 and 5‐HT4 receptor antagonists to modify the disinhibitory profile of diazepam and other agents was… 
Highly Cited
1993
1993
1993
This pilot clinical trial was a 15-week, double-blind, controlled, three-way crossover study evaluating cognitive effects of… 
1993
1993
Objective: To investigate the effect of the new angiotensin converting enzyme inhibitor ceranapril (1 mg/kg) on the cerebral… 
Highly Cited
1992
Highly Cited
1992
In these studies, we have investigated possible cognition-enhancing effects of angiotensin-converting enzyme (ACE) inhibition…